Cipla reports 33% fall in Q4 consolidated net profit

30 May 2020 Evaluate

Cipla has reported results for the fourth quarter and year ended March 31, 2020.

The Company has reported a fall of 4.65% in its net profit at Rs 604.57 crore for the quarter under review as compared to Rs 634.07 crore for the same quarter in the previous year. Total income of the company decreased by 0.11% at Rs 3546.85 crore for Q4FY20 as compared Rs 3550.92 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 33.02% in its net profit attributable to shareholders of the company of Rs 245.95 crore for the quarter under review as compared to Rs 367.20 crore for the same quarter in the previous year. Total income of the company decreased by 0.67% at Rs 4469.37 crore for Q4FY20 as compared Rs 4499.34 crore for the corresponding quarter previous year.

For the year ended March 31, 2020, the company has reported a rise of 22.76% in its net profit at Rs 2318.17 crore as compared to Rs 1888.41 crore for the previous year. Total income of the company increased by 4.64% at Rs 13552.00 crore for year under review as compared to Rs 12951.53 crore for year ended March 31, 2019.

For the year ended March 31, 2020, on the consolidated basis, the company has reported a rise of 1.23% in its net profit attributable to shareholders of the company of Rs 1546.52 crore as compared to Rs 1527.70 crore for the previous year. Total income of the company increased by 3.78% at Rs 17476.19 crore for year under review as compared to Rs 16838.98 crore for year ended March 31, 2019.

 

Cipla Share Price

1345.35 -2.30 (-0.17%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.